Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Biochem ; 267(10): 2973-80, 2000 May.
Article in English | MEDLINE | ID: mdl-10806396

ABSTRACT

The association of rat brain hexokinase with heterologous recombinant yeast mitochondria harboring human porin (Yh) is comparable to that with rat liver mitochondria in terms of cation requirements, cooperativity in binding, and the effect of amphipathic compounds. Mg2+, which is required for hexokinase binding to all mitochondria, can be replaced by other cations. The efficiency of hexokinases, however, depends on the valence of hydrophilic cations, or the partition of hydrophobic cations in the membrane, implying that these act by reducing a prohibitive negative surface charge density on the outer membrane rather than fulfilling a specific structural requirement. Macromolecular crowding (using dextran) has dual effects. Dextran added in excess increases hexokinase binding to yeast mitochondria, according to the porin molecule they harbor. This effect, significant with wild-type yeast mitochondria, is only marginal with Yh as well as rat mitochondria. On the other hand, an increase in the number of hexokinase binding sites on mitochondria is also observed. This increase, moderate in wild-type organelles, is more pronounced with Yh. Finally, dextran, which has no effect on the modulation of hexokinase binding by cations, abolishes the inhibitory effect of amphipathic compounds. Thus, while hexokinase binding to mitochondria is predetermined by the porin molecule, the organization of the latter in the membrane plays a critical role as well, indicative that porin must associate with other mitochondrial components to form competent binding sites on the outer membrane.


Subject(s)
Brain/enzymology , Hexokinase/metabolism , Mitochondria/metabolism , Recombinant Proteins/metabolism , Animals , Anticoagulants/pharmacology , Antifungal Agents/pharmacology , Calcium/metabolism , Cations/pharmacology , Clotrimazole/pharmacology , Dextrans/pharmacology , Dose-Response Relationship, Drug , Ethylenediamines/pharmacology , Hexokinase/chemistry , Humans , Imidazoles/pharmacology , Liver/enzymology , Magnesium/metabolism , Magnesium Chloride/pharmacology , Models, Chemical , Organometallic Compounds/pharmacology , Porins/genetics , Porins/metabolism , Protein Binding , Rats , Rats, Sprague-Dawley , Recombinant Proteins/chemistry , Saccharomyces cerevisiae/enzymology , Spermidine/pharmacology
2.
J Bioenerg Biomembr ; 31(6): 569-79, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10682915

ABSTRACT

The association in vitro of rat brain hexokinase to mitochondria from rat liver or yeast (wild type, porinless, or expressing recombinant human porin) was studied in an effort to identify minimal requirements for each component. A short hydrophobic N-terminal peptide of hexokinase, readily cleavable by proteases, is absolutely required for its binding to all mitochondria. Mammalian porins are significantly cleaved at two positions in putative cytoplasmic loops around residues 110 and 200, as determined by proteolytic-fragment identification using antibodies. Recombinant human porin in yeast mitochondria is more sensitive to proteolysis than wild-type porin in rat liver mitochondria. Recombinant yeast mitochondria, harboring several natural or engineered porins from various sources, bind hexokinase to variable extent with marked preference for the mammalian porin1 isoform. Genetic alteration of this isoform at the C-, but not the N-terminal, results in a significant reduction of hexokinase binding ability. Macromolecular crowding (dextran) promotes a stronger association of the enzyme to all recombinant mitochondria, as well as to proteolytically digested organelles. Consequently, brain hexokinase association with heterologous mitochondria (yeast) in these conditions occurs to an extent comparable to that with homologous (rat) mitochondria. The study, also pertinent to the topology and organization of porin in the membrane, represents a necessary first step in the functional investigation of the physiological role of mammalian hexokinase binding to mitochondria in reconstituted heterologous recombinant systems, as models to cellular metabolism.


Subject(s)
Brain/enzymology , Hexokinase/metabolism , Mitochondria/metabolism , Saccharomyces cerevisiae/ultrastructure , Animals , Catalysis/drug effects , Dextrans/pharmacology , Hexokinase/drug effects , Humans , Mice , Mitochondria/chemistry , Peptide Hydrolases/metabolism , Porins/metabolism , Porins/pharmacology , Protein Engineering , Rats , Rats, Sprague-Dawley , Receptors, Cell Surface/drug effects , Receptors, Cell Surface/metabolism , Triticum/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...